We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
IFITM1 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
2018.9
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
9788.6
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
8478.9
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
8316.5
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
7175.2
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
6385.8
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
6272.4
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
5976.5
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
5812.2
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
5689.8
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
5685.2
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
5615.2
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
5591.9
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
5258.0
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
5257.1
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
5162.0
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
5071.3
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
4952.4
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
4691.0
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
4668.7
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
4660.5
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
4640.2
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
4614.1
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
4573.5
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
4525.1
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
4504.4
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
4416.3
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
4380.8
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
4373.9
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
4372.9
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
4357.6
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
4273.0
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
4263.3
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
4243.7
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
4208.6
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
4143.7
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
4125.2
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
4082.8
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
4053.8
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
4019.5
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
3980.9
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
3955.6
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
3916.6
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
3909.6
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
3909.2
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
3902.6
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
3857.3
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
3852.0
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
3845.3
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
3810.0
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
3785.2
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
3654.7
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
3641.5
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
3639.2
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
3618.7
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
3591.7
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
3589.3
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
3554.6
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
3543.2
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
3540.2
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
3536.8
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
3522.0
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
3499.2
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
3359.3
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
3356.6
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
3337.9
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
3258.6
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
3257.8
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
3244.9
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
3169.1
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
3122.3
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
3074.0
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
3073.0
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
3066.7
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
3051.9
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
2987.6
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
2987.5
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
2952.0
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
2941.6
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
2888.6
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
2888.2
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
2887.5
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
2874.3
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
2829.4
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
2753.9
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
2725.5
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
2715.2
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
2710.1
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
2687.9
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
2677.5
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
2669.9
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
2659.1
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
2652.1
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
2641.9
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
2625.1
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
2614.7
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
2582.7
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
2577.4
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
2547.8
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
2544.8
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
2506.4
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
2484.5
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
2438.9
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
2431.3
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
2418.3
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
2414.4
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
2412.6
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
2386.2
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
2368.3
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
2362.9
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
2346.2
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
2335.2
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
2326.6
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
2298.5
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
2293.0
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
2291.1
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
2289.1
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
2285.5
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
2285.0
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
2284.6
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
2268.2
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
2249.6
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
2238.2
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
2231.9
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
2220.7
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
2217.6
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
2206.6
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
2191.4
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
2182.7
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
2179.7
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
2172.9
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
2140.5
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
2130.4
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
2125.9
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
2116.0
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
2097.2
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
2079.4
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
2071.4
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
2071.0
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
2043.7
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
2043.6
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
2041.3
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
2022.9
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
2007.9
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
1995.6
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
1985.4
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
1975.5
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
1975.5
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
1936.1
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
1932.4
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
1920.1
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
1919.6
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
1913.9
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
1909.5
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
1904.0
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
1902.0
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
1899.7
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
1876.5
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
1876.2
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
1867.4
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
1863.2
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
1857.7
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
1850.5
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1848.1
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
1846.8
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
1844.7
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
1831.8
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
1805.9
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
1787.0
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
1774.4
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
1772.7
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
1766.2
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
1753.2
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
1748.1
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
1748.1
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
1722.4
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
1721.7
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
1702.5
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
1685.4
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
1668.1
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
1649.8
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
1636.3
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
1627.6
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
1627.2
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
1620.8
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
1599.0
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
1584.9
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
1580.9
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
1561.8
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
1560.9
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
1514.1
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
1504.9
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
1485.6
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
1482.4
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
1481.1
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
1473.0
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
1472.4
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
1471.4
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
1466.4
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
1437.4
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
1429.0
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
1428.3
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
1408.7
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
1407.6
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
1384.7
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
1383.6
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
1383.5
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
1379.3
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
1374.1
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
1360.1
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
1339.6
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
1338.5
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
1337.0
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
1333.7
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
1329.7
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
1314.5
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
1306.7
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
1279.4
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
1272.8
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
1264.3
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
1258.7
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
1248.3
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
1239.9
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
1221.5
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
1206.2
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
1205.2
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
1193.6
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
1183.9
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
1147.4
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
1145.5
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
1145.4
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
1122.9
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
1115.5
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
1114.3
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
1101.3
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
1093.9
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
1092.9
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
1087.0
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
1084.0
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
1077.2
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
1050.6
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
1035.9
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
1034.7
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
1020.8
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
1014.5
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
1007.0
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
1004.9
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
1001.0
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
997.3
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
969.6
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
951.5
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
948.0
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
947.7
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
940.9
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
932.9
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
930.2
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
923.5
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
910.2
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
874.1
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
873.5
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
873.0
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
864.9
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
851.6
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
849.9
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
844.6
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
842.0
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
839.2
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
837.3
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
826.0
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
813.4
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
801.2
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
790.1
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
789.1
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
779.3
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
773.1
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
769.5
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
767.6
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
763.4
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
761.8
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
737.4
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
722.2
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
713.6
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
709.5
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
698.2
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
693.3
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
666.4
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
662.3
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
645.3
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
639.4
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
634.1
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
631.5
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
625.1
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
622.9
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
612.5
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
610.7
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
598.3
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
596.0
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
581.1
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
580.7
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
550.1
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
540.2
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
533.6
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
533.2
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
529.3
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
526.5
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
515.8
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
512.0
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
508.9
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
477.0
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
474.9
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
473.0
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
421.5
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
385.9
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
385.8
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
374.6
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
364.2
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
347.6
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
347.3
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
340.3
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
335.2
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
323.4
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
309.1
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
306.3
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
294.7
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
289.6
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
285.4
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
276.0
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
275.6
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
275.6
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
248.5
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
246.4
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
245.3
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
241.1
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
238.3
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
237.9
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
236.8
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
231.5
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
204.5
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
193.4
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
187.9
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
163.3
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
152.3
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
104.7
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
102.6
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
78.1
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
73.7
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
68.4
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
57.1
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
56.8
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
IFITM1 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
701.7
Number of samples
81
Samples
Sample
Description
pTPM
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
3532.7
DO46568
66 years, female, NA, stage:III, dead, 320 days
2898.2
DO46376
58 years, female, NA, stage:III, dead, 1430 days
2233.6
DO46412
64 years, female, NA, stage:III, dead, 597 days
1932.8
DO46404
55 years, female, NA, stage:III, dead, 690 days
1850.0
DO46354
73 years, female, NA, stage:III, dead, 843 days
1722.8
DO46392
48 years, female, NA, stage:III, dead, 628 days
1700.9
DO46528
56 years, female, NA, stage:III, alive, 6139 days
1685.9
DO46362
61 years, female, NA, stage:III, dead, 1639 days
1368.3
DO46364
45 years, female, NA, stage:III, dead, 806 days
1291.6
DO46591
58 years, female, NA, stage:III, dead, 195 days
1257.5
DO46602
74 years, female, NA, stage:III, dead, 205 days
1189.0
DO46378
59 years, female, NA, stage:III, alive, 843 days
1121.2
DO46386
49 years, female, NA, stage:III, dead, 1162 days
1094.5
DO46384
55 years, female, NA, stage:III, dead, 614 days
1075.0
DO46443
59 years, female, NA, stage:III, dead, 2464 days
1059.2
DO46340
62 years, female, NA, stage:III, dead, 616 days
1035.0
DO46326
51 years, female, NA, stage:III, dead, 701 days
991.0
DO46329
52 years, female, NA, stage:III, dead, 1699 days
924.2
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
894.4
DO46352
60 years, female, NA, stage:III, dead, 677 days
888.6
DO46560
45 years, female, NA, stage:IV, dead, 286 days
879.5
DO46342
67 years, female, NA, stage:III, dead, 1398 days
851.3
DO46388
74 years, female, NA, stage:III, dead, 413 days
824.4
DO46344
46 years, female, NA, stage:III, dead, 642 days
823.0
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
793.0
DO46546
73 years, female, NA, stage:III, dead, 1889 days
786.4
DO46581
66 years, female, NA, stage:III, dead, 408 days
779.4
DO46380
51 years, female, NA, stage:III, dead, 1423 days
727.7
DO46453
66 years, female, NA, stage:III, dead, 3294 days
718.8
DO46396
64 years, female, NA, stage:III, dead, 583 days
707.5
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
701.3
DO46336
70 years, female, NA, stage:IV, dead, 664 days
679.5
DO46468
67 years, female, NA, stage:III, alive, 2776 days
631.9
DO46586
55 years, female, NA, stage:III, dead, 1019 days
599.2
DO46332
56 years, female, NA, stage:III, dead, 689 days
590.6
DO46382
62 years, female, NA, stage:IV, dead, 311 days
589.3
DO46346
54 years, female, NA, stage:III, dead, 1187 days
572.5
DO46334
77 years, female, NA, stage:III, dead, 496 days
538.1
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
532.8
DO46448
45 years, female, NA, stage:III, dead, 654 days
515.8
DO46398
66 years, female, NA, stage:III, alive, 437 days
499.9
DO46330
60 years, female, NA, stage:III, dead, 684 days
482.0
DO46327
54 years, female, NA, stage:III, dead, 184 days
476.9
DO46566
78 years, female, NA, stage:III, dead, 673 days
437.2
DO46325
54 years, female, NA, stage:III, dead, 477 days
435.0
DO46493
62 years, female, NA, stage:IV, alive, 839 days
432.3
DO46533
46 years, female, NA, stage:III, alive, 3667 days
412.2
DO46372
39 years, female, NA, stage:III, dead, 1326 days
410.7
DO46402
77 years, female, NA, stage:III, dead, 511 days
410.0
DO46408
56 years, female, NA, stage:III, dead, 489 days
396.8
DO46597
60 years, female, NA, stage:III, dead, 393 days
396.2
DO46576
75 years, female, NA, stage:III, alive, 133 days
381.1
DO46432
56 years, female, NA, stage:III, alive, 2218 days
368.6
DO46508
50 years, female, NA, stage:III, dead, 2101 days
364.3
DO46333
58 years, female, NA, stage:III, dead, 359 days
351.7
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
341.2
DO46551
58 years, female, NA, stage:III, dead, 1055 days
334.9
DO46350
66 years, female, NA, stage:III, dead, 886 days
325.9
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
308.5
DO46328
52 years, female, NA, stage:III, dead, 972 days
305.8
DO46463
49 years, female, NA, stage:III, dead, 2451 days
295.6
DO46436
58 years, female, NA, stage:III, alive, 3193 days
282.3
DO46518
62 years, female, NA, stage:III, alive, 2960 days
278.5
DO46356
68 years, female, NA, stage:III, dead, 911 days
270.7
DO46368
57 years, female, NA, stage:III, dead, 2879 days
256.3
DO46348
58 years, female, NA, stage:IV, dead, 287 days
251.7
DO46370
54 years, female, NA, stage:III, dead, 1727 days
243.6
DO46538
57 years, female, NA, stage:III, dead, 1527 days
240.8
DO46358
60 years, female, NA, stage:III, dead, 423 days
236.9
DO46571
61 years, female, NA, stage:III, dead, 243 days
184.1
DO46561
52 years, female, NA, stage:III, dead, 195 days
181.4
DO46331
72 years, female, NA, stage:III, dead, 612 days
120.6
DO46366
65 years, female, NA, stage:III, dead, 2054 days
119.6
DO46338
59 years, female, NA, stage:III, dead, 596 days
79.0
DO46390
65 years, female, NA, stage:III, dead, 374 days
71.2
DO46606
73 years, female, NA, stage:III, alive, 804 days
70.6
DO46588
74 years, female, NA, stage:III, dead, 438 days
62.9
DO46611
52 years, female, NA, stage:III, dead, 734 days
51.0
DO46374
69 years, female, NA, stage:III, dead, 1409 days
50.9
DO46400
70 years, female, NA, stage:III, dead, 719 days
36.4
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
N/A
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
N/A
21efd60f-6a31-4b98-9477-16a905_D2
Normal
N/A
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
N/A
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
N/A
285fed94-1495-448e-879b-b55de9_D2
Tumor
N/A
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
N/A
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
N/A
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
N/A
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
N/A
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
N/A
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
N/A
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
N/A
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
N/A
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
N/A
2f901c90-617e-46da-9fac-d68369_D2
Tumor
N/A
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
N/A
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
N/A
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
N/A
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
N/A
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
N/A
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
N/A
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
N/A
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
N/A
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
N/A
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
N/A
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
N/A
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
N/A
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
N/A
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
N/A
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
N/A
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
N/A
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
N/A
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
N/A
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
N/A
1772e913-f62e-446a-8cf3-720348_D2
Tumor
N/A
e9d416e7-f661-400a-896e-388545_D2
Tumor
N/A
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
N/A
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
N/A
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
N/A
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
N/A
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
N/A
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
N/A
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
N/A
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
N/A
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
N/A
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
N/A
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
N/A
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
N/A
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
N/A
10c2d629-0287-4511-ac25-f29031_D2
Tumor
N/A
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
N/A
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
N/A
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
N/A
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
N/A
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
N/A
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
N/A
340a3769-3031-41ae-bb08-a2f696_D2
Normal
N/A
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
N/A
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
N/A
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
N/A
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
N/A
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
N/A
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
N/A
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
N/A
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
N/A
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
N/A
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
N/A
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
N/A
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
N/A
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
N/A
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
N/A
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
N/A
15524912-685a-47ce-a824-567848_D2
Tumor
N/A
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
N/A
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
N/A
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
N/A
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
N/A
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
N/A
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
N/A
a3a26070-fb84-406a-8280-d555e6_D2
Normal
N/A
161317f3-1a39-438e-af45-cd2502_D2
Tumor
N/A
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
N/A
1db5574d-aca7-403c-8100-6e705f_D2
Normal
N/A
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
N/A
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
N/A
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
N/A
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
N/A
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
N/A
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
N/A
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
N/A
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
N/A
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
N/A
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
N/A
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
N/A
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
N/A
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
N/A
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
N/A
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
N/A
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
N/A
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
N/A
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
N/A
a65d8e76-640f-4341-a561-afbb57_D2
Normal
N/A
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
N/A
1a10c200-3895-4648-b951-94f99f_D2
Tumor
N/A
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
N/A
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
N/A
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
N/A
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
